Novo Nordisk A/S NOVO.B-DK:Copenhagen Stock Exchange

RT Quote | Exchange | DKK
Last | 4:59 PM CET
437.95quote price arrow down-5.00 (-1.13%)
Volume
2,846,892
52 week range
417.55 - 466.55

...

Loading . . .

KEY STATS

  • Open443.00
  • Day High449.30
  • Day Low436.40
  • Prev Close442.95
  • 52 Week High466.55
  • 52 Week High Date02/18/21
  • 52 Week Low417.55
  • 52 Week Low Date01/06/21
  • Market Cap170,841.67M
  • Shares Out2,301.56M
  • 10 Day Average Volume2.19M
  • Dividend9.10
  • Dividend Yield2.08%
  • Beta0.83
  • 1 Year % Change4.16

RATIOS/PROFITABILITY

  • EPS (TTM)18.08
  • P/E (TTM)24.22
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/14/2020
  • Div Amount3.25
  • Split Date-
  • Split Factor-

Latest Novo Nordisk A/S News

There is no recent news for this security.

Latest NOVO.B-DK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral...
Helge Lund
Chairman
Jeppe Christiansen
Vice Chairman
Lars Fruergaard Joergensen
President
Maziar Doustdar
Chief Operating Officer
Karsten Munk Knudsen
Chief Financial Officer
Doug Langa
Executive Vice President
Address
Novo Alle 1
Bagsvaerd
2880
Denmark